Literature DB >> 4338586

Accumulation of adenosine 3':5'-cyclic monophosphate in clonal glial cells: labeling of intracellular adenine nucleotides with radioactive adenine.

J Schultz, B Hamprecht, J W Daly.   

Abstract

The accumulation of endogenous adenosine 3':5'-cyclic phosphate (cAMP) and of [(14)C]cAMP, derived from nucleotides labeled by prior incubation of cells with [(14)C]adenine, has been investigated in four glial cell lines from rats. The following results are similar to data reported for brain slices: (i) rat glial cells contain a system that readily incorporates [(14)C]adenine into nucleotides that serve as precursors for cAMP. (ii) norepinephrine stimulates accumulation of both [(14)C]cAMP and endogenous cAMP, and (iii) the phosphodiesterase inhibitors, papaverine and isobutylmethylxanthine, are effective in enhancing the stimulatory effect of norepinephrine. In contrast to results reported for brain slices, histamine, veratridine, and adenosine, the purine either alone or with a biogenic amine, do not cause an enhanced accumulation of cAMP in rat glial cells, and repetitive accumulations of cAMP can be elicited during a series of restimulations of the cells with norepinephrine. The magnitude of the accumulation of cAMP elicited by the catecholamine decreases markedly by the fifth restimulation in the absence of, but only slightly in the presence of, papaverine. In glial cells, a large portion of the [(14)C]adenine is incorporated into intracellular compounds that do not serve as precursors of [(14)C]cAMP.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338586      PMCID: PMC426678          DOI: 10.1073/pnas.69.5.1266

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Factors influencing the accumulation of cyclic AMP in brain tissue.

Authors:  T W Rall; A Sattin
Journal:  Adv Biochem Psychopharmacol       Date:  1970

2.  Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity.

Authors:  J A Beavo; N L Rogers; O B Crofford; J G Hardman; E W Sutherland; E V Newman
Journal:  Mol Pharmacol       Date:  1970-11       Impact factor: 4.436

3.  Formation of cyclic adenosine 3',5'-monophosphate from adenosine in brain slices.

Authors:  H Shimizu; J Daly
Journal:  Biochim Biophys Acta       Date:  1970-11-24

4.  A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain.

Authors:  H Shimizu; J W Daly; C R Creveling
Journal:  J Neurochem       Date:  1969-12       Impact factor: 5.372

5.  Effect of aging on the adenyl cyclase and phosphodiesterase activity of isolated fat cells of rat.

Authors:  J Forn; P S Schonhofer; I F Skidmore; G Krishna
Journal:  Biochim Biophys Acta       Date:  1970-05-12

6.  The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum.

Authors:  S Kakiuchi; T W Rall
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

7.  Differentiated rat glial cell strain in tissue culture.

Authors:  P Benda; J Lightbody; G Sato; L Levine; W Sweet
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

8.  Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity.

Authors:  H R Bourne; R I Lehrer; M J Cline; K L Melmon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

9.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

10.  Regulation of adenosine 3':5'-cyclic monophosphate concentration in cultured human astrocytoma cells by catecholamines and histamine.

Authors:  R B Clark; J P Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

View more
  11 in total

1.  Quantifying agonist activity at G protein-coupled receptors.

Authors:  Frederick J Ehlert; Hinako Suga; Michael T Griffin
Journal:  J Vis Exp       Date:  2011-12-26       Impact factor: 1.355

2.  Prolonged prostaglandin E1 stimulation of cyclic AMP production in transformed and normal WI-38 fibroblasts.

Authors:  F J Chlapowski; K P Ray; R W Butcher
Journal:  In Vitro       Date:  1978-11

3.  Adenosine Receptors: The Contributions by John W. Daly.

Authors:  Bertil B Fredholm; Kenneth A Jacobson
Journal:  Heterocycles       Date:  2009       Impact factor: 0.831

4.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

5.  Is there a "dopaminergic glial cell"?

Authors:  E Hansson; L Rönnbäck; A Sellström
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

6.  Turnover of protein-bound serine phosphate in respiring slices of guinea-pig cerebral cortex. Effects of putative transmitters, tetrodotoxin and other agents.

Authors:  M Reddington; R Rodnight; M Williams
Journal:  Biochem J       Date:  1973-03       Impact factor: 3.857

7.  Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase of C-6 glioma cells.

Authors:  J P Schwartz; J V Passonneau
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

8.  Noradrenaline-refractoriness in cultured glioma cells.

Authors:  J Oey
Journal:  Exp Brain Res       Date:  1976-06-30       Impact factor: 1.972

9.  Adenosine-mediated elevation of cyclic 3':5'-adenosine monophosphate concentrations in cultured mouse neuroblastoma cells.

Authors:  A J Blume; C Dalton; H Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

10.  Similarities of adenosine uptake systems in astrocytes and neurons in primary cultures.

Authors:  A S Bender; L Hertz
Journal:  Neurochem Res       Date:  1986-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.